Overall, CPT is a natural anti‐oestrogen agent and could inhibit ERα‐mediated IGF‐1/AKT/mTOR pathway to increase the sensitivity of the ERα‐positive resistant breast cancer cells. The gene discussed is AKT1; the disease is breast carcinoma.